Perspective Therapeutics (CATX) Enterprise Value (2010 - 2026)
Perspective Therapeutics (CATX) posted Enterprise Value of -$487.9 million for Q1 2026, down 237.06% sequentially from -$144.7 million in Q4 2025, and down 28.72% YoY from -$684.5 million in Q1 2025.
Perspective Therapeutics (CATX) Enterprise Value (2010 - 2026) Analysis & Trends
Perspective Therapeutics has reported Enterprise Value for 17 years, with the latest figure at -$487.9 million in Q1 2026.
- Quarterly Enterprise Value fell 28.72% year-over-year to -$487.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$487.9 million (down 28.72% YoY) and the FY2025 annual result came in at -$144.7 million, up 36.22% from the prior year.
- Enterprise Value retreated to -$487.9 million in Q1 2026 per CATX's latest filing, from -$144.7 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$9.2 million in Q4 2023 and troughed at -$487.9 million in Q1 2026.
- A 5-year average of -$167.9 million and a median of -$144.7 million in 2025 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2024: Enterprise Value jumped 78.89% in 2023, then tumbled 2356.33% in 2024.
- Over 5 years, Enterprise Value stood at -$43.8 million in 2022, then surged by 78.89% to -$9.2 million in 2023, then sank by 2356.33% to -$226.9 million in 2024, then jumped by 36.22% to -$144.7 million in 2025, then sank by 237.06% to -$487.9 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$487.9 million, -$144.7 million, and -$174.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | -4.95 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | -3.48 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | -297.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | -4.15 Bn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | -1.95 Bn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | -1.88 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | -3.29 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | -467.80 Mn |
| 10 | Perspective Therapeutics | 387.89 Mn | 387.89 Mn | - | -425.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -425.29 Mn |
| Mar 31, 2026 | -487.86 Mn |
| Dec 31, 2025 | -144.74 Mn |
| Sep 30, 2025 | -174.14 Mn |
| Jun 30, 2025 | -354.33 Mn |
| Mar 31, 2025 | -379.00 Mn |
| Dec 31, 2024 | -226.92 Mn |
| Sep 30, 2024 | -309.20 Mn |
| Jun 30, 2024 | -292.87 Mn |
| Mar 31, 2024 | -180.65 Mn |
| Dec 31, 2023 | -9.24 Mn |
| Sep 30, 2023 | -17.98 Mn |
| Jun 30, 2023 | -28.32 Mn |
| Mar 31, 2023 | -36.45 Mn |
| Dec 31, 2022 | -43.76 Mn |
| Sep 30, 2022 | -54.11 Mn |
| Jun 30, 2022 | -55.89 Mn |
| Mar 31, 2022 | -58.90 Mn |
| Dec 31, 2021 | -60.35 Mn |
| Sep 30, 2021 | -61.69 Mn |